These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 34566919)
1. Prudent Use of Tylosin for Treatment of Huang A; Wang S; Guo J; Gu Y; Li J; Huang L; Wang X; Tao Y; Liu Z; Yuan Z; Hao H Front Microbiol; 2021; 12():712473. PubMed ID: 34566919 [TBL] [Abstract][Full Text] [Related]
2. Rational Use of Danofloxacin for Treatment of Wang S; Huang A; Gu Y; Li J; Huang L; Wang X; Tao Y; Liu Z; Wu C; Yuan Z; Hao H Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326865 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Tylosin and Tilmicosin Against Experimental Garmyn A; Vereecken M; De Gussem K; Depondt W; Haesebrouck F; Martel A Avian Dis; 2019 Jun; 63(2):359-365. PubMed ID: 31251538 [TBL] [Abstract][Full Text] [Related]
4. Optimal Regimens and Clinical Breakpoint of Avilamycin Against Huang A; Luo X; Xu Z; Huang L; Wang X; Xie S; Pan Y; Fang S; Liu Z; Yuan Z; Hao H Front Pharmacol; 2022; 13():769539. PubMed ID: 35281904 [No Abstract] [Full Text] [Related]
5. Huang Z; Wu Y; Zhou Z; Xia X; Gu X; Cai Q; Shen X; Yang H; Ding H Front Pharmacol; 2019; 10():670. PubMed ID: 31293418 [No Abstract] [Full Text] [Related]
6. Exploration of Clinical Breakpoint of Danofloxacin for Xu Z; Huang A; Luo X; Zhang P; Huang L; Wang X; Mi K; Fang S; Huang X; Li J; Yuan Z; Hao H Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356730 [No Abstract] [Full Text] [Related]
7. Clinical Breakpoint of Apramycin to Swine Dai X; Gu Y; Guo J; Huang L; Cheng G; Peng D; Hao H Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163350 [TBL] [Abstract][Full Text] [Related]
8. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks. Jordan FT; Horrocks BK Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs. Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum. Xiao X; Sun J; Yang T; Fang X; Cheng J; Xiong YQ; Liu YH Front Vet Sci; 2016; 3():75. PubMed ID: 27656647 [TBL] [Abstract][Full Text] [Related]
11. Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China. Mi K; Sun D; Li M; Hao H; Zhou K; Liu Z; Yuan Z; Huang L Pathogens; 2021 Jan; 10(2):. PubMed ID: 33498972 [No Abstract] [Full Text] [Related]
12. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens. Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809 [TBL] [Abstract][Full Text] [Related]
13. The PK-PD Relationship and Resistance Development of Danofloxacin against Zhang N; Wu Y; Huang Z; Yao L; Zhang L; Cai Q; Shen X; Jiang H; Ding H Front Microbiol; 2017; 8():926. PubMed ID: 28611739 [No Abstract] [Full Text] [Related]
14. Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Zhang N; Zhou M; Yan X; Liu J; Yuan S; Yang H; Ding H; Zhang D; Bai Y Front Vet Sci; 2022; 9():952599. PubMed ID: 36246335 [No Abstract] [Full Text] [Related]
15. Comparison of the pharmacokinetics of tilmicosin in plasma and lung tissue in healthy chickens and chickens experimentally infected with Mycoplasma gallisepticum. Zhang N; Liu Z; Wei Y; Zhang C; Mao C; Cai Q; Shen X; Ding H J Vet Pharmacol Ther; 2020 Jul; 43(4):347-354. PubMed ID: 32133660 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum. Jordan FT; Forrester CA; Ripley PH; Burch DG Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842 [TBL] [Abstract][Full Text] [Related]
17. Optimal Regimens and Cutoff Evaluation of Tildipirosin Against Lei Z; Liu Q; Qi Y; Yang B; Khaliq H; Xiong J; Moku GK; Ahmed S; Li K; Zhang H; Zhang W; Cao J; He Q Front Pharmacol; 2018; 9():765. PubMed ID: 30093860 [No Abstract] [Full Text] [Related]
18. Field evaluation of tylosin premix in layers previously vaccinated with a live Mycoplasma gallisepticum vaccine. Evans RD; Trites JD; Cochrane RL Avian Dis; 2002; 46(1):208-14. PubMed ID: 11922337 [TBL] [Abstract][Full Text] [Related]
19. Determination of Susceptibility Breakpoint for Cefquinome against Mi K; Li M; Sun L; Hou Y; Zhou K; Hao H; Pan Y; Liu Z; Xie C; Huang L Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439008 [No Abstract] [Full Text] [Related]
20. In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance. Cooper AC; Fuller JR; Fuller MK; Whittlestone P; Wise DR Res Vet Sci; 1993 May; 54(3):329-34. PubMed ID: 8393208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]